Hepatic fibrosis, a progressive pathological development in MASH, is primarily driven by hepatic stellate cells (HSCs), whose activation is strongly influenced by the pro-inflammatory environment established by KCs [22,23]. Here, TBCE is linked to metabolic dysfunction-associated steatohepatitis.